Heart Test Laboratories Stock Today
Heart Test is selling for under 0.04 as of the 4th of May 2025; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.04. The performance scores are derived for the period starting the 3rd of February 2025 and ending today, the 4th of May 2025. Click here to learn more.
Valuation
Check how we calculate scores
Heart Stock Highlights
| President CEO | Andrew Simpson |
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Heart Test Laboratories (HSCSW) is traded on NASDAQ Exchange in USA. It is located in 550 Reserve Street, Southlake, TX, United States, 76092 and employs 15 people. Heart Test is listed under Medical Equipment category by Fama And French industry classification. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry.
Heart Test Laboratories has accumulated about 723.48 K in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Heart Test Probability Of Bankruptcy
Heart Stock Against Markets
Heart Test Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Heart Test stock to make a market-neutral strategy. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Heart Test Corporate Executives
Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.